Evolution of Secondary Findings in Acute Cholecystitis: A Temporal Analysis from Point-of-Care Ultrasound to Subsequent Imaging.
Dian Ivanov, David Cannata, Kyle A Chin...
https://pubmed.ncbi.nlm.nih.gov/41016303/Actively Recruiting
Led by WellSpan Health · Updated on 2026-08-28
90
Participants Needed
1
Research Sites
26 weeks
Total Duration
Researchers are evaluating the usefulness of repeating a point-of-care ultrasound POCUS of the gallbladder in adult emergency department patients who have abdominal pain but an initial ultrasound that is unclear or negative for acute cholecystitis. This study aims to find out if a repeat ultrasound can help doctors identify gallbladder inflammation earlier and improve diagnosis accuracy in these patients. Acute cholecystitis is a common cause of abdominal pain leading to emergency visits, and early detection is important to guide treatment decisions. Participants will receive a repeat biliary point-of-care ultrasound performed by trained emergency physicians 2 to 6 hours after their first ultrasound while still in the emergency department. The repeat ultrasound will look for changes in the gallbladder such as wall thickening, fluid around the gallbladder, tenderness, and diameter changes. The study is a single-group interventional trial where all enrolled patients undergo this repeat imaging. Data on diagnoses, consultations, additional imaging, and interventions will be collected for comparison. During the study, participants will be monitored for up to 30 days after enrollment to track diagnoses of acute cholecystitis or other biliary diseases, the need for specialty consultation, further imaging, and biliary interventions. Researchers will review ultrasound findings, clinical outcomes, and medical records. The main outcome is the number of patients diagnosed with acute cholecystitis within 30 days. Secondary measures include detailed ultrasound changes within hours and other clinical follow-up information to assess the value of repeat ultrasound in emergency care.
CONDITIONS
Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis
B
Brent Becker Principal Investigator, MD
K
Kristen Wilhelm Research Coordinator, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
WellSpan Health
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Repeat point-of-care ultrasound | Standard diagnostic imaging pathway |
|---|---|---|
| What it is | A repeat bedside ultrasound of the gallbladder performed 2–6 hours after an initial non‑diagnostic ultrasound in patients with continued symptoms | Standard imaging may include CT of the abdomen or hepatobiliary iminodiacetic acid (HIDA) scan |
| Primary use | To improve diagnostic accuracy by detecting evolving signs of acute cholecystitis earlier in the emergency department | To establish diagnosis of acute cholecystitis when ultrasound is equivocal or negative despite clinical suspicion |
| How it is performed | Performed by the emergency clinician at the bedside using ultrasound 2–6 hours after initial scan | Performed off-site using CT imaging or HIDA nuclear scan according to local radiology protocols |
| Evidence status | No prospective evidence yet exists to support repeat POCUS for early cholecystitis detection | CT and HIDA are established diagnostic methods when ultrasound findings are inconclusive |
| Important limitations | Potential for delayed diagnosis if repeat imaging misses early inflammation; depends on operator skill and symptom persistence | Additional imaging may delay diagnosis, increase cost and radiation exposure, and may not be available immediately |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 2 to 6 hours after initial ultrasound
Participants undergo a repeat biliary point-of-care ultrasound 2 to 6 hours after their initial ultrasound while still in the emergency department. Researchers observe ultrasound findings and collect clinical data.
1 visit (in-person)
Duration - Up to 30 days after enrollment
Participants are followed for up to 30 days to track diagnoses, consultations, additional imaging, and interventions related to biliary disease.
Follow-up assessments via medical record review
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Dian Ivanov, David Cannata, Kyle A Chin...
https://pubmed.ncbi.nlm.nih.gov/41016303/Jared R Gallaher, Anthony Charles
https://pubmed.ncbi.nlm.nih.gov/35258527/WellSpan Health
Lead Sponsor